[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market Tue, 12th Jan 2021 Article tags Covid-19 testingIn-vitro diagnosticsMolecular Diagnostics (MDx)AsiaEuropeGlobalIVD GatewayMolecular Diagnostics (MDx) EIU Healthcare zooms in on two of the fastest-growing molecular testing areas: cancer and Covid-19 testing to uncover the market opportunities for IVD companies. In this webinar, EIU Healthcare discusses our outlook on the molecular diagnostics (MDx) market, covering: • Covid-19 impact: How has the Covid-19 pandemic impacted the global MDx market for instruments and test areas • Laboratory insights: How is the molecular testing environment in Asia and Europe evolving? • New players: What are some emerging players to watch and how will they shape up competition in the market? • New technologies: How will the growing adoption of molecular testing impact the use of more traditional diagnostic technologies? Watch webinar on-demand Fill out the form to access the webinar recording. IVD Gateway: IVD Market and Forecasts with Covid-19 ImpactThe go-to-source for Covid-19 impact on In-Vitro Diagnostics test demand in 2020 and market recovery trends in 2021 for all 130+ IVD test segments across countries in Asia, Europe and Latin America. Find out more Tue, 12th Jan 2021 Article tags Covid-19 testingIn-vitro diagnosticsMolecular Diagnostics (MDx)AsiaEuropeGlobalIVD GatewayMolecular Diagnostics (MDx)
IVD Gateway: IVD Market and Forecasts with Covid-19 ImpactThe go-to-source for Covid-19 impact on In-Vitro Diagnostics test demand in 2020 and market recovery trends in 2021 for all 130+ IVD test segments across countries in Asia, Europe and Latin America. Find out more